Joel I Ward

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)
    Joel I Ward
    University of California Los Angeles UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, David Geffen School of Medicine UCLA, Torrance, California 90502 2502, USA
    Clin Infect Dis 43:151-7. 2006
  2. ncbi Efficacy of an acellular pertussis vaccine among adolescents and adults
    Joel I Ward
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, David Geffen School of Medicine, UCLA, Torrance, Calif 90502, USA
    N Engl J Med 353:1555-63. 2005
  3. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
  4. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
  5. ncbi Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population
    Jagmohan S Batra
    Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson St, Torrance, CA 90502, USA
    Pediatrics 123:951-8. 2009
  6. ncbi Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults
    James D Cherry
    University of CaliforniaLos Angeles Center for Vaccine Research, Research and Education Institute, Harbor UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
    Clin Infect Dis 39:1715-8. 2004
  7. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson Street, Torrance, CA 90502, USA
    Vaccine 21:1894-900. 2003
  8. ncbi Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis
    Kenneth W Purdy
    University of California-Los Angeles (UCLA) Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, Torrance, CA 90502-2502, USA
    Clin Infect Dis 39:20-8. 2004
  9. ncbi Importance of new combination vaccines
    Joel I Ward
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, UCLA School of Medicine, 1124 W. Carson Street RB3, Torrance, CA 90502, USA
    Clin Pediatr (Phila) 43:503-4. 2004
  10. ncbi Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project
    Eileen M Eriksen
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 23:656-62. 2004

Collaborators

Detail Information

Publications16

  1. ncbi Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)
    Joel I Ward
    University of California Los Angeles UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, David Geffen School of Medicine UCLA, Torrance, California 90502 2502, USA
    Clin Infect Dis 43:151-7. 2006
    ..Acellular pertussis (aP) booster immunizations have been recommended for adolescents and older persons to enhance long-term protection and to possibly reduce community transmission of infections...
  2. ncbi Efficacy of an acellular pertussis vaccine among adolescents and adults
    Joel I Ward
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, David Geffen School of Medicine, UCLA, Torrance, Calif 90502, USA
    N Engl J Med 353:1555-63. 2005
    ..CONCLUSIONS: The acellular pertussis vaccine was protective among adolescents and adults, and its routine use might reduce the overall disease burden and transmission to children...
  3. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
    ..Streptococcus pneumoniae (Sp) is an important bacterial pathogen in children. Nasopharyngeal (NP) colonization of S. pneumoniae is necessary for person-to-person transmission and often precedes invasive disease...
  4. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
    ....
  5. ncbi Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population
    Jagmohan S Batra
    Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson St, Torrance, CA 90502, USA
    Pediatrics 123:951-8. 2009
    ..This study assesses and compares age- and dose-specific immunization coverage in children of different birth weight categories during the first year of life...
  6. ncbi Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults
    James D Cherry
    University of CaliforniaLos Angeles Center for Vaccine Research, Research and Education Institute, Harbor UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
    Clin Infect Dis 39:1715-8. 2004
    ..There was minimal variation in antibody prevalence with respect to geographic area, age, sex, or race...
  7. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson Street, Torrance, CA 90502, USA
    Vaccine 21:1894-900. 2003
    ....
  8. ncbi Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis
    Kenneth W Purdy
    University of California-Los Angeles (UCLA) Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, Torrance, CA 90502-2502, USA
    Clin Infect Dis 39:20-8. 2004
    ..A recommendation for booster vaccinations every 10 years requires more information about duration of immunity, program costs, compliance, and nonmedical costs associated with pertussis...
  9. ncbi Importance of new combination vaccines
    Joel I Ward
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, UCLA School of Medicine, 1124 W. Carson Street RB3, Torrance, CA 90502, USA
    Clin Pediatr (Phila) 43:503-4. 2004
  10. ncbi Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project
    Eileen M Eriksen
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 23:656-62. 2004
    ..CONCLUSIONS: A relationship between HBV and neonatal death was not identified...
  11. ncbi Acellular pertussis vaccines and complement killing of Bordetella pertussis
    Alison A Weiss
    Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0524, USA
    Infect Immun 72:7346-51. 2004
    ..The responses of the other individuals were complex, with evidence of both beneficial and antagonistic responses occurring, sometimes in the same individual...
  12. ncbi Economic considerations for pertussis booster vaccination in adolescents
    Joel W Hay
    Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, CA 90089 USA
    Pediatr Infect Dis J 24:S127-33. 2005
    ..These new vaccines for adolescents and adults are safe, immunogenic, and protective...
  13. ncbi Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study
    Thuan Le
    UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance 90502, USA
    J Infect Dis 190:535-44. 2004
    ..These findings support the use of ACP booster immunizations for adolescents and adults, to provide sustained levels of antibody...
  14. ncbi Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells
    Scott H Millen
    Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Infect Immun 72:615-20. 2004
    ..the convalescent group had higher titers in the PBMC assay. Results for pertussis toxin neutralization with the CHO assay appear to be distinct from those with the PBMC assay...
  15. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
    ..CONCLUSIONS: Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule...
  16. ncbi Kinetics of maternal hepatitis a antibody decay in infants: implications for vaccine use
    Jay M Lieberman
    Miller Children s Hospital Long Beach, CA 90806, USA
    Pediatr Infect Dis J 21:347-8. 2002
    ..These data indicate that maternal antibody levels remained high through the first 6 months of life but decayed significantly by 12 months of age...